ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,417 | +64.2% | 11,569 | 0.0% | 0.00% | – |
| Q1 2023 | $25,221 | -82.3% | 11,569 | -2.2% | 0.00% | – |
| Q4 2022 | $142,339 | +58.2% | 11,832 | -15.0% | 0.00% | – |
| Q3 2022 | $90,000 | +45.2% | 13,925 | +2.1% | 0.00% | – |
| Q2 2022 | $62,000 | -97.5% | 13,640 | -95.2% | 0.00% | – |
| Q1 2022 | $2,443,000 | -29.6% | 282,378 | +16.1% | 0.00% | -100.0% |
| Q4 2021 | $3,472,000 | -30.1% | 243,125 | +7.7% | 0.00% | 0.0% |
| Q3 2021 | $4,964,000 | +75.8% | 225,831 | +7.0% | 0.00% | – |
| Q2 2021 | $2,824,000 | +5034.5% | 211,082 | +1055.4% | 0.00% | – |
| Q4 2018 | $55,000 | -37.5% | 18,269 | +1.4% | 0.00% | – |
| Q3 2018 | $88,000 | – | 18,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 290,501 | $2,513,000 | 1.83% |
| Knoll Capital Management, LLC | 20,000 | $173,000 | 0.11% |
| Private Portfolio Partners LLC | 42,250 | $365,463 | 0.09% |
| Rossmore Private Capital | 40,661 | $352,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 54,233 | $469,000 | 0.04% |
| Cubist Systematic Strategies, LLC | 241,892 | $2,092,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 662,000 | $5,726,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 550,956 | $4,766,000 | 0.01% |
| Jump Financial, LLC | 34,800 | $301,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 264,824 | $2,291,000 | 0.01% |